PharmaLex Group establishes a new service line for compliance and quality services
The merger with the compliance and quality specialist company, Complya Consulting Group, supports a key strategic goal and builds on PharmaLex’s recent US-based acquisitions
Friedrichsdorf, GERMANY / Boston, MA, USA, May 15th 2017: As of 2nd May, 2017, the PharmaLex Group, a leading specialist provider of development consulting and scientific affairs, regulatory affairs and pharmacovigilance, has completed the merger of Complya Consulting Group.
Complya was founded in 2007 by Jonathan Morse and is based in Boston, MA, USA. Their main area of expertise is US FDA GXP Quality Assurance services. Alongside this Complya also provide a spectrum of related consulting services, including GCP/GLP/GMP Quality Assurance and Regulatory Affairs support. These services complement the extensive PharmaLex service portfolio. Complya has a US and international client base of innovative start-up organizations through to major pharmaceutical companies. Following this acquisition, and together with the most recent acquisitions of Safis Solution and The Degge Group, the PharmaLex Group now has one the largest US pool of experts supporting pharmaceutical and biotech companies with their health authority obligations.
“The merger enables PharmaLex to build on its existing US FDA Quality and Compliance expertise”, explained Dr. Thomas Dobmeyer, CEO PharmaLex. Dr. Tilo Netzer, CEO PharmaLex, added, “The ability to enhance our Quality and Compliance service capabilities will help to position us as a key provider within the US market. We can now provide the complete spectrum of services to support the requirements of health authorities in all mature markets – from regulatory strategy to quality assurance services”. “By joining the PharmaLex Group, Complya is now even better positioned to serve clients in new markets and locations, and to provide valuable new services to our existing clients in Boston and internationally” said Jonathan Morse, CEO, Complya Consulting.
The PharmaLex Group now has over 650 employees, with 25 offices in 12 countries and more than 600 satisfied clients worldwide.
About PharmaLex <Confidence beyond compliance>:
PharmaLex combines local expertise with global reach in the area of development consulting and scientific services, regulatory affairs and pharmacovigilance. A proven track record of success in outsourcing programs, more than 25,000 successfully completed projects for over 650 clients worldwide, as well as extensive experience in all therapeutic areas and product groups, including advanced therapy medicinal products and biopharmaceuticals, medical and borderline products and alternative therapeutic approaches.
For further information, please contact:
Ms. Eva Keck
Director Business Development Operations, PharmaLex GmbH email@example.com +49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim, Germany